StockData
TransMedics Group, Inc. logo

TransMedics Group, Inc. (TMDX) stock

TMDXNasdaqElectromedical & Electrotherapeutic ApparatusFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 5, 2026Score 14/3029% below fair value
$96.43+2.52 (+2.68%)

Close on Nov 18, 2026Market cap $3.34BP/E 25.0Yield 0.00%

TransMedics market cap

Market capitalization is the share price multiplied by the number of shares outstanding.

TransMedics's market cap was $3.19B on Nov 11, 2026, against $5.00B a year earlier. Over the last 5 years it ranged from $440.63M to $5.60B, with a median of $2.58B.

Market Cap at the end of each year

PeriodPeriod endValueChange
2026Nov 11, 2026$3.19B-23.3%
2025Dec 31, 2025$4.15B+98.5%
2024Dec 31, 2024$2.09B-18.8%
2023Dec 29, 2023$2.58B+30.7%
2022Dec 30, 2022$1.97B+270.5%
2021Dec 31, 2021$531.98M-1.6%
2020Dec 31, 2020$540.47M+206.7%
2019Dec 31, 2019$176.21M–

More TransMedics figures

See a number that looks wrong?